The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Watkins Thomas since 2006.
This trader's CIK number is 1307935.
At the time of last reporting, Watkins Thomas was the Director of Horizon Therapeutics Public Ltd Co. (stock ticker symbol HZNP).
Also see all insider trading activities at Horizon Therapeutics Public Ltd Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | HZNP | 0 | $0 | 0 | $0 | 85,236 | $1,141,774 |
| 2022 | HZNP | 0 | $0 | 0 | $0 | 4,223 | $0 |
| 2021 | HZNP | 0 | $0 | 0 | $0 | 11,098 | $0 |
| 2020 | HZNP | 0 | $0 | 0 | $0 | 15,390 | $0 |
| 2019 | HZNP | 0 | $0 | 0 | $0 | 15,320 | $0 |
| 2017 | HZNP | 0 | $0 | 0 | $0 | 13,953 | $0 |
| 2015 | HZNP | 16,000 | $371,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | VNDA | 0 | $0 | 12,882 | $127,556 | 30,000 | $124,500 |
| 2021 | VNDA | 0 | $0 | 5,818 | $107,854 | 15,000 | $106,650 |
| 2020 | VNDA | 0 | $0 | 9,677 | $111,285 | 15,000 | $110,700 |
| 2018 | VNDA | 0 | $0 | 0 | $0 | 15,000 | $74,700 |
| 2014 | VNDA | 0 | $0 | 35,000 | $618,170 | 35,000 | $329,000 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | HGSI | 60,000 | $1,449,600 | 0 | $0 | 0 | $0 |
| 2010 | HGSI | 801 | $15,731 | 0 | $0 | 0 | $0 |
| 2009 | HGSI | 1,000 | $1,800 | 0 | $0 | 0 | $0 |
| 2008 | HGSI | 122,281 | $310,940 | 0 | $0 | 0 | $0 |
| 2007 | HGSI | 1,992 | $15,119 | 0 | $0 | 0 | $0 |
| 2006 | HGSI | 36,000 | $406,500 | 0 | $0 | 0 | $0 |
1. Horizon Therapeutics Public Ltd Co (HZNP)
2. Vanda Pharmaceuticals Inc. (VNDA)
3. Human Genome Sciences Inc (HGSI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-29 | HZNP | Option Ex | 81,323 | 14.04 | 1,141,774 |
| 2023-04-28 | HZNP | Option Ex | 3,913 | .00 | 0 |
| 2022-04-29 | HZNP | Option Ex | 4,223 | .00 | 0 |
| 2021-04-30 | HZNP | Option Ex | 11,098 | .00 | 0 |
| 2020-05-02 | HZNP | Option Ex | 15,390 | .00 | 0 |
| 2019-05-03 | HZNP | Option Ex | 15,320 | .00 | 0 |
| 2017-05-03 | HZNP | Option Ex | 13,953 | .00 | 0 |
| 2015-08-19 | HZNP | Buy | 10,000 | 31.32 | 313,240 |
| 2014-08-14 | HZNP | Buy | 6,000 | 9.76 | 58,560 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-02 | VNDA | Option Ex | 15,000 | 4.15 | 62,250 |
| 2022-06-02 | VNDA | Sale | 6,441 | 9.90 | 63,778 |
| 2022-06-02 | VNDA | Option Ex | 15,000 | 4.15 | 62,250 |
| 2022-06-02 | VNDA | Sale | 6,441 | 9.90 | 63,778 |
| 2021-02-16 | VNDA | Sale | 5,818 | 18.54 | 107,854 |
| 2021-02-16 | VNDA | Option Ex | 15,000 | 7.11 | 106,650 |
| 2020-05-29 | VNDA | Option Ex | 15,000 | 7.38 | 110,700 |
| 2020-05-29 | VNDA | Sale | 9,677 | 11.50 | 111,285 |
| 2018-05-03 | VNDA | Option Ex | 15,000 | 4.98 | 74,700 |
| 2014-03-14 | VNDA | Option Ex | 35,000 | 9.40 | 329,000 |
| 2014-03-14 | VNDA | Sale | 35,000 | 17.66 | 618,170 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-01-05 | HGSI | Buy | 60,000 | 24.16 | 1,449,600 |
| 2010-07-12 | HGSI | Buy | 801 | 19.64 | 15,731 |
| 2009-06-30 | HGSI | Buy | 1,000 | 1.80 | 1,800 |
| 2008-11-12 | HGSI | Buy | 100,000 | 2.02 | 202,000 |
| 2008-07-01 | HGSI | Buy | 2,281 | 4.49 | 10,241 |
| 2008-03-11 | HGSI | Buy | 20,000 | 4.93 | 98,699 |
| 2007-07-11 | HGSI | Buy | 1,992 | 7.59 | 15,119 |
| 2006-11-10 | HGSI | Buy | 6,000 | 12.05 | 72,300 |
| 2006-09-05 | HGSI | Buy | 30,000 | 11.14 | 334,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Watkins Thomas (Director of Horizon Therapeutics Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.